v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT04983823 |
|
Full text link
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
joel.smith@baker.edu.au |
|
Registration date
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
2021-07-30 |
|
Recruitment status
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Recruiting |
|
Study design
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Long covid |
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: history of covid-19 infection live within a geographically accessible area for follow-up |
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
valvular stenosis or regurgitation of >moderate severity history of previous heart failure (baseline new york heart association (nyha) classification >2) inability to acquire interpretable images (identified from baseline echo) contraindications to beta blockers or angiotensin-converting enzyme inhibitors oncologic (or other) life expectancy <12 months or any other medical condition (including pregnancy) that results in the belief (deemed by the chief investigators) that it is not appropriate for the patient to participate in this trial already taking both angiotensin converting enzyme inhibitors/ angiotensin receptor blockers and beta blockers, or intolerance (or allergy) to both. mobility impairment that would impact participants' ability to perform exercise unable to provide written informed consent to participate in this study |
|
Number of arms
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Baker Heart and Diabetes Institute |
|
Inclusion age min
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
50 |
|
Inclusion age max
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
85 |
|
Countries
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Australia |
|
Type of patients
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
|
Severity scale
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
820 |
|
primary outcome
Last imported at : Feb. 3, 2023, 8 p.m. Source : ClinicalTrials.gov |
Change in exercise capacity |
|
Notes
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : July 31, 2021, 1 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1830, "treatment_name": "Cardio-covid disease management plan (cc-dmp)", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |